山河药辅
(300452)
| 流通市值：22.60亿 | | | 总市值：26.68亿 |
| 流通股本：1.99亿 | | | 总股本：2.34亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 768,425,139.19 | 521,648,673.91 | 261,391,437.57 | 942,795,401.5 |
| 营业总成本 | 636,892,846.4 | 426,933,973.05 | 210,786,022.15 | 777,028,261.41 |
| 其他经营收益 | | | | |
| 营业利润 | 142,786,471.59 | 110,664,610.1 | 54,419,874.15 | 199,110,475.85 |
| 利润总额 | 143,080,553.82 | 110,896,848.55 | 54,460,906.03 | 198,684,951.99 |
| 净利润 | 125,882,735.17 | 97,095,867.82 | 47,475,434.97 | 173,174,700.26 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 125,882,735.17 | 97,095,867.82 | 47,475,434.97 | 173,174,700.26 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,231,612,509.94 | 1,231,893,886.2 | 1,201,499,458.37 | 1,151,772,876.43 |
| 非流动资产: | | | | |
| 非流动资产合计 | 578,998,572.48 | 556,448,330.15 | 555,931,267.91 | 561,122,840.25 |
| 资产总计 | 1,810,611,082.42 | 1,788,342,216.35 | 1,757,430,726.28 | 1,712,895,716.68 |
| 流动负债: | | | | |
| 流动负债合计 | 315,101,786.08 | 322,350,244.16 | 273,528,091.15 | 278,261,182.14 |
| 非流动负债: | | | | |
| 非流动负债合计 | 363,850,432.8 | 363,291,902.09 | 361,740,053.35 | 360,936,252.37 |
| 负债合计 | 678,952,218.88 | 685,642,146.25 | 635,268,144.5 | 639,197,434.51 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,064,010,358.22 | 1,034,671,550.46 | 1,054,664,738.63 | 1,006,655,014.85 |
| 股东权益合计 | 1,131,658,863.54 | 1,102,700,070.1 | 1,122,162,581.78 | 1,073,698,282.17 |
| 负债和股东权益合计 | 1,810,611,082.42 | 1,788,342,216.35 | 1,757,430,726.28 | 1,712,895,716.68 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 709,220,223.72 | 466,736,005.04 | 203,685,876.83 | 879,280,895.16 |
| 经营活动现金流出小计 | 568,173,536.32 | 375,727,494.1 | 189,211,317.98 | 687,291,441.39 |
| 经营活动产生的现金流量净额 | 141,046,687.4 | 91,008,510.94 | 14,474,558.85 | 191,989,453.77 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 637,116,527.95 | 409,246,525.12 | 164,676,758.08 | 648,920,526.54 |
| 投资活动现金流出小计 | 839,972,085.42 | 488,434,708.7 | 215,785,003.74 | 675,741,731.74 |
| 投资活动产生的现金流量净额 | -202,855,557.47 | -79,188,183.58 | -51,108,245.66 | -26,821,205.2 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 47,471,496.6 | 42,679,337.87 | 12,000,000 | 18,481,937.13 |
| 筹资活动现金流出小计 | 85,085,012.91 | 84,950,890.68 | 2,012,133.35 | 87,672,476.07 |
| 筹资活动产生的现金流量净额 | -37,613,516.31 | -42,271,552.81 | 9,987,866.65 | -69,190,538.94 |
| 汇率变动对现金及现金等价物的影响 | -3,054,837.15 | -2,278,434.82 | -1,316,352 | -573,844.6 |
| 现金及现金等价物净增加额 | -102,477,223.53 | -32,729,660.27 | -27,962,172.16 | 95,403,865.03 |
| 期末现金及现金等价物余额 | 162,438,126.2 | 232,185,689.46 | 236,953,177.57 | 264,915,349.73 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -32,729,660.27 | - | 95,403,865.03 |